AbbVie (ABBV)

Large pharmaceutical company spun off from Abbott in 2013, with immunology blockbusters Skyrizi and Rinvoq succeeding Humira, plus the Allergan aesthetics portfolio (Botox).

Legal name: AbbVie Inc.
Ticker: ABBV
Exchange: New York Stock Exchange · MIC XNYS
Country: United States
Sector: Healthcare
Industry: Pharmaceuticals
Market cap ≈: $390bn (approx., seed-0.4 · 2026-08-28)
Reporting currency: USD
Founded: 2013
Website: www.abbvie.com
LEI: FR5LCKFTG8054YNNRU85 (GLEIF)
ISIN: US00287Y1091 (check digit validated)
FIGI: BBG0025Y4RZ3 (share class, OpenFIGI)

Graph connections view in graph →

lists_onNew York Stock Exchange
domiciled_inUnited States member_ofS&P 500

Sector peers — Healthcare

Eli Lilly · UnitedHealth Group · Johnson & Johnson · Merck & Co. · Thermo Fisher Scientific · Abbott

Approximate reference values from public sources · seed-0.4 · 2026-08-28 · not real-time. See data & methodology.

# this page as data GET https://finance.foundation/api/v1/companies/abbvie